Globavend
3 hedge funds and large institutions have $27.7K invested in Globavend in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
11% less capital invested
Capital invested by funds: $31.1K → $27.7K (-$3.45K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$4.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$1.91K |
GVH Hedge Fund Activity: Q4 2024 in Review
3 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Globavend (GVH) for Q4 2024, worth a combined $27.7K — down 11% from $31.1K a quarter earlier.
Fund positioning in GVH was balanced in Q4 2024: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $4.4K. The largest seller was Two Sigma Securities, cutting an estimated $1.91K.
- 3 institutional investors held Globavend (GVH) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $27.7K of Globavend stock for Q4 2024, down 11% quarter-over-quarter.
- 0 funds opened new Globavend positions in Q4 2024 and 0 closed out.
- The largest Globavend buyer in Q4 2024 was UBS Group, an estimated $4.4K added.
- The largest Globavend seller in Q4 2024 was Two Sigma Securities, an estimated $1.91K sold.
Based on aggregated 13F filings for Q4 2024.